Bill White
Analyst · Oppenheimer. Please go ahead
Thank you, Brian and a good day to our shareholders, guests and listeners. I'd like to discuss some of the financial information that was contained in our press release for the fourth quarter and fiscal year ending December 31, 2019, which we released this afternoon. I'll begin with our fourth-quarter results; revenue for the fourth quarter ended December 31, 2019 grew 118% to $2,897,000 versus $1,330,000 for the same period last year. Our software as a service revenue was approximately $2,557,000 for Q4 2019, a 209% increase from $826,000 and Q4 2018 and with a 64% sequential increase versus approximately $1,564,000 in Q3 2019. Gross profit as a percentage of revenue was 88.8% for the quarter ended December 31, 2019 compared to 93.1% for the quarter ended December 31, 2018. Operating expenses which consists of selling, G&A and research and development expenses increased by 28% or $547,000 to approximately $2.5 million versus $1,953,000 in the prior year. The increase was primarily driven by an increase in sales commissions due to increased sales development personnel to support our growth and new annual incentive bonus plan, which is contended to bond achieving certain goals established by the Board of Directors and Compensation Committee. The company posted net income of $106,000 for the three months ending December 31, 2019 compared to a net loss of $664,000 for the quarter ending December 31, 2018. The net income per diluted share was $0.01 versus a net loss per diluted share of $0.04 in the prior year. Adjusted EBITDA for the quarter ended December 31, 2019 was $216,000 compared to a negative $633,000 in the quarter ended December 31, 2018. Now turning to our full year 2019 results; revenue for the full year ended December 31, 2018 was up 73% to $7.67 million compared to $4.43 million for the prior year. Our SaaS revenue for the calendar year 2019 was $6.1 million an increase of 126% as compared to $2.66 million in the prior year. Driven by growth in our SaaS business, gross profit as a percentage of revenue was 87% for the year ended December 31, 2019 compared to 91.3% for the prior year. Operating expenses were $9.3 million for the year ended December 31, 2019 from $8.1 million for the year ended December 31, 2018. Selling, general and administrative expense increased 8% to $5.7 million for the year ended December 31, 2019 from $5.2 million for the prior year, primarily as a result of increased stock-based compensation expense, sales commissions and a new annual incentive bonus program which is contingent upon certain goals being achieved as set by the Board of Directors and Compensation Committee. research and development expenses increased 26% to $3.7 million for the year ended December 31, 2019 from $2.9 million for the year ended December 31, 2018 driven by increased development personnel and the new annual incentive bonus plan as previously mentioned, offset by decreases in outside research and development efforts. The company had a net loss of $2.5 million for the year ended December 31, 2019 as compared to $4 million for the calendar year 2018. The net loss per diluted share was $0.16 versus $0.26 in the prior year period. Weighted average share count were $15.7 million and $15.5 million respectively. Adjusted EBITDA was a negative $1.8 million for 2019 an improvement of approximately $1.9 million as compared to adjusted EBITDA of a negative $3.7 million for 2018. Interest and other income was $99,000 for the year ended December 31, 2019 compared to $130,000 during the year end December 31, 2018. I'd like to now focus on the company's liquidity and capital resources. As of December 31, 2019, the company had cash of $3.4 million, working capital to fund its current assets minus current liabilities of $3.2 million, total assets of $14 million and stockholders' equity of $11.7 million. During the year ending December 31, 2019 the company's net cash of approximately $1 million compared to net cash used of $3.6 million during the year ended December 31, 2018. Net cash used in operating activities was $1.8 million for the year ended December 31, 2019 compared to $4.2 million for the same period in 2018. Net cash provided by investing activities was $22,000 for the year compared to a net cash used by investing activities of $100,000 for the year ended December 31, 2018 and we generated cash of $794,000 from financing activities in 2019 compared to generating net cash of $688,000 from financing activities in 2018. On February 06, 2018 the company entered into a revolving credit facility with Citibank. This agreement allows for maximum borrowings of $2 million secured by collateral accountant and bears interest at Citibank space rate of minus 2%. As of today there are no amounts outstanding under this facility. We currently anticipate that our available cash as well as expected cash from operations and available under the revolving credit facility will be sufficient to meet our anticipated working capital and capital expenditure requirements for at least the next 12 months. As of December 31, 2019 the company had net operating loss carry forwards of approximately $17 million. I'll now turn the call back over to the operator to take your questions, operator?